| P50 | author | Kenji Kashiwagi | Q60986734 |
| | Toyoaki Tsumura | Q96200728 |
| P2093 | author name string | Shigeo Tsukahara | |
| | Satoshi Kogure | |
| | Tatsuya Chiba | |
| | Teruhiko Goto | |
| | Fumihiko Mabuchi | |
| | Fumiko Kashiwagi | |
| | Takashi Shibuya | |
| | Kiyotaka Ishijima | |
| | Shu Omoto | |
| | Takaharu Tokunaga | |
| | Kazuyoshi Kitamura | |
| | Jhoji Tanabe | |
| | Osamu Hosaka | |
| | Tadaharu Tsuchiya | |
| | Takashi Godo | |
| | Tetsunori Saito | |
| P2860 | cites work | A Novel Grading Method for Superficial Punctate Keratopathy Magnitude and Its Correlation With Corneal Epithelial Permeability | Q44650379 |
| | Spirometry for patients prescribed topical beta-blockers. | Q51719613 |
| | Pharmacokinetics, Efficacy, and Safety of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% in Healthy Volunteers: A Phase I Comparison vs. the Corresponding Preservative-free Monotherapies. | Q53343133 |
| | Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy | Q84120625 |
| | Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination | Q28552385 |
| | Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). | Q31134303 |
| | Bronchial reactivity in healthy individuals undergoing long-term topical treatment with beta-blockers | Q33210746 |
| | Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community | Q33886940 |
| | Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients | Q35315104 |
| | Resting pulse rates in a glaucoma clinic: the effect of topical and systemic beta-blocker usage | Q36085655 |
| | Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost | Q36709208 |
| | Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project | Q37243715 |
| | Prospective Observational Post-marketing Study of Tafluprost 0.0015%/Timolol 0.5% Combination Ophthalmic Solution for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety | Q37444732 |
| | Persistence of patients receiving topical glaucoma monotherapy in an Asian population | Q37827285 |
| | Effects of antiglaucoma drugs on the ocular surface in rabbits: a fixed-combination drug versus two concomitant drugs | Q38470550 |
| | The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study | Q41015854 |
| | Systemic adverse effects of topical ophthalmic agents. Implications for older patients | Q41634574 |
| | Determinants of adherence to glaucoma medical therapy in a long-term patient population | Q42615263 |
| | Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. | Q42628471 |
| | Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure | Q44414154 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 8456764 | |
| P577 | publication date | 2018-02-21 | |
| P1433 | published in | Journal of Ophthalmology | Q26842872 |
| P1476 | title | Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy. | |
| P478 | volume | 2018 | |